TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
TransMedics Group (TMDX) Tops Q4 EPS by 9c; Guides FY23 Reveneus Above Views
February 22, 2023 4:40 PM ESTTransMedics Group (NASDAQ: TMDX) reported Q4 EPS of ($0.21), $0.09 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $31.4 million versus the consensus estimate of $24.45 million.
GUIDANCE:
TransMedics Group sees FY2023 revenue of $138-145 million, versus the consensus of... More
